Fang Liu, MD
Children's Hospital of Fudan University · The Third Affiliated Hospital of Harbin Medical University · Chengdu Military General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fang Liu, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:46 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07686770 · Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki DiseaseChildren's Hospital of Fudan University · not yet recruiting · Kawasaki Disease · study director
- Ph2NCT07398560 · Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical StudyThe Third Affiliated Hospital of Harbin Medical University · not yet recruiting · Small Cell Lung Cancer · principal investigator
- N/ANCT06993636 · Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsChildren's Hospital of Fudan University · recruiting · Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban · study director
- Ph4NCT06978439 · Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseChildren's Hospital of Fudan University · recruiting · Kawasaki Disease, Pilot Study, Coronary Artery Aneurysm · study director
- Ph4NCT05643651 · Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseChildren's Hospital of Fudan University · recruiting · Kawasaki Disease, Coronary Artery Aneurysm · study director
- Ph1NCT04162353 · BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid LymphomaiCell Gene Therapeutics · recruiting · Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma · principal investigator
- Ph1NCT04162340 · CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell MalignanciesiCell Gene Therapeutics · unknown · T Cell Lymphoma in Relapse, Refractory T-Cell Lymphoma · principal investigator
- Early Ph1NCT04156243 · CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell MalignanciesiCell Gene Therapeutics · unknown · B Cell Lymphoma, B Cell Leukemia · principal investigator
- Early Ph1NCT04156269 · BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple MyelomaiCell Gene Therapeutics · unknown · Multiple Myeloma · principal investigator
- Early Ph1NCT04156256 · CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesiCell Gene Therapeutics · unknown · Hematologic Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Early Ph1NCT04156178 · CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell MalignanciesiCell Gene Therapeutics · unknown · B Cell Lymphoma, B Cell Leukemia · principal investigator
- Ph3NCT04078568 · Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki DiseaseChildren's Hospital of Fudan University · completed · Kawasaki Disease · study director
- N/ANCT03915795 · Statins Study in Kawasaki Disease Children With Coronary Artery AbnormalitiesChildren's Hospital of Fudan University · completed · Kawasaki Disease, Coronary Artery Abnormalities · study director
- Early Ph1NCT03795779 · CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesiCell Gene Therapeutics · unknown · Hematologic Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.